Funding news
Serinus Biosciences logo

Serinus Biosciences Raises $1.1

Recently funded · $1.1M SeedTechnology, Information and MediaView source

Get the full Serinus Biosciences company profile

Access contacts, investors, buying signals & more

Open in Dashboard

An AI drug discovery company aiming to unlock tens of thousands of previously undruggable targets, Serinus Biosciences has closed a $1.1M seed round. The startup specializes in designing small molecule disrupters for protein-protein interactions (PPIs), a notoriously challenging area in drug development.

Serinus Biosciences leverages a proprietary proteome-wide interface energetics map to transform natural protein ligands into small molecule binding opportunities. Its PPI-specific generative AI engine is designed to accelerate the discovery of potent, synthetically accessible interface binding hits, reducing development timelines from years to months.

Other recently funded companies

View all

Biggest recent AI rounds

Largest funding rounds in AI on Signalbase right now.

#CompanyAmount
1
Nuance Healthcare logo

Nuance Healthcare

United States

$19.7B
2
OpenAI logo

OpenAI

United States

$13.0B
3
Anthropic logo

Anthropic

$13.0B
4
Preferred Networks, Inc. logo

Preferred Networks, Inc.

Japan

¥10.0B
5
AIMAX logo

AIMAX

United Kingdom

$10.0B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Rude logo

Rude

Norway

$100.0K
2
PrimaHealth Credit logo

PrimaHealth Credit

United States

$3.0M
3
Xigma Accountants logo

Xigma Accountants

Australia

$100.0K
4
Senaptec logo

Senaptec

United States

$100.0K
5
Robolink logo

Robolink

United States

$220.0K